Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec;34(52):e2201051.
doi: 10.1002/adma.202201051. Epub 2022 Aug 7.

Intelligent Micro-/Nanorobots for Cancer Theragnostic

Affiliations
Review

Intelligent Micro-/Nanorobots for Cancer Theragnostic

Jie Wang et al. Adv Mater. 2022 Dec.

Abstract

Cancer is one of the most intractable diseases owing to its high mortality rate and lack of effective diagnostic and treatment tools. Advancements in micro-/nanorobot (MNR)-assisted sensing, imaging, and therapeutics offer unprecedented opportunities to develop MNR-based cancer theragnostic platforms. Unlike ordinary nanoparticles, which exhibit Brownian motion in biofluids, MNRs overcome viscous resistance in an ultralow Reynolds number (Re << 1) environment by effective self-propulsion. This unique locomotion property has motivated the advanced design and functionalization of MNRs as a basis for next-generation cancer-therapy platforms, which offer the potential for precise distribution and improved permeation of therapeutic agents. Enhanced barrier penetration, imaging-guided operation, and biosensing are additionally studied to enable the promising cancer-related applications of MNRs. Herein, the recent advances in MNR-based cancer therapy are comprehensively addresses, including actuation engines, diagnostics, medical imaging, and targeted drug delivery; promising research opportunities that can have a profound impact on cancer therapy over the next decade is highlighted.

Keywords: drug delivery; medical imaging; micro-/nanorobotics; tumor diagnosis; tumor therapy.

PubMed Disclaimer

References

    1. A. Aalipour, H. Y. Chuang, S. Murty, A. L. D'Souza, S. M. Park, G. S. Gulati, C. B. Patel, C. Beinat, F. Simonetta, I. Martinic, G. Gowrishankar, E. R. Robinson, E. Aalipour, Z. Zhian, S. S. Gambhir, Nat. Biotechnol. 2019, 37, 531.
    1. S. Lee, C. A. Schmitt, Nat. Cell Biol. 2019, 21, 94.
    1. N. Pashayan, P. D. P. Pharoah, Science 2020, 368, 589.
    1. M. Fernandez-Medina, M. A. Ramos-Docampo, O. Hovorka, V. Salgueirino, B. Stadler, Adv. Funct. Mater. 2020, 30, 1908283.
    1. S. K. Srivastava, G. Clergeaud, T. L. Andresen, A. Boisen, Adv. Drug Delivery Rev. 2019, 138, 41.

LinkOut - more resources